Steve Mankoff and David Wroe have joined the strategic advisory board of Genstar Capital. Mankoff is the former senior VP of global and technical services at Siebel Systems, while Wroe was chairman and CEO of Agency Management Systems (now Vertafore).
Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of the life science, healthcare services, software, financial services, and industrial technology industries, today announced that it has named veteran technology executives Steve Mankoff and David W. Wroe as members of the firm’s Strategic Advisory Board (SAB).
Mr. Mankoff was previously Senior Vice President Global and Technical Services at Siebel Systems, Inc. and has over 20 years of experience in the software industry. Mr. Wroe is a senior software and insurance executive who, during his 40-year career, served as Chairman and CEO of Agency Management Systems, Inc., the largest U.S. insurance agency software provider (now Vertafore).
“From their senior executive positions with some of the world’s leading technology companies Steve and David will bring invaluable insights to our firm and portfolio companies,” said Jean-Pierre L. Conte, Genstar’s Chairman and Managing Director. “We have been working with both Steve and David for several years. They have already been valuable contributors to Genstar’s efforts in our software and financial services verticals and we are delighted that they have agreed to join our Strategic Advisory Board. Genstar’s investment philosophy is contingent on driving operational improvements to drive returns and our two newest advisory board members will greatly enhance our ability to create value and build promising businesses.”
During his tenure at Siebel, Mr. Mankoff was a member of the Founder’s Circle of its first employees and the Siebel executive management team. Siebel was acquired by Oracle Corporation in 2006. During his tenure at Siebel, he was responsible for global Expert Services, Education, Professional Services, and Quality Engineering among other areas. He serves as a member of the Board of Directors of ConvergeOne, Nomis Solutions, SignalDemand, and Virtual Instruments and on the Strategic Advisory Board of C3. He is a graduate of Brown University and received his Master of Science in Management from MIT Sloan School of Management.
Mr. Wroe has a wealth of senior-level insurance and IT experience accumulated during his extensive career. He served as senior vice president and chief technology officer of Chicago-based CNA, one of the world’s premier insurance organizations, from 1996 to 2001. From 1983 to 1996, Mr. Wroe served as Chairman and CEO of AMS, building AMS into the largest provider of automation services to insurance agents with a customer base exceeding 20,000 agencies. He had joined AMS in 1981 when asked to head AMS development after its acquisition by Commercial Union. He is currently providing consulting services through Clareworks. He is a graduate of Providence College.
Genstar Capital’s Strategic Advisory Board provides portfolio companies with a rich source of operating experience and strategic insight. The committee is composed of influential senior executives who are current or former leaders of major corporations who work directly with Genstar and its portfolio companies – as Board members and advisors – to develop strategic plans, expand market opportunities, source acquisitions and recruit executives and board members. The SAB includes executives who have served in senior capacities with such leading companies as Abbott Laboratories, Andersen Consulting, Pharmacia & Upjohn, CNA Insurance Companies, ITT Corporation, Oracle, Ingersoll Rand, Axia Health Management, MedImmune, Inc., WellPoint, Siebel Systems, and ICOS Corporation.
About Genstar Capital, LLC
Genstar Capital (www.gencap.com) is a leading private equity firm that for over 20 years has been actively investing in high quality middle-market companies. Based in San Francisco, Genstar works in partnership with its management teams and its network of operating talent and strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life sciences, healthcare services, financial & business services, software & software services and industrial technology industries.